Physician profile
Nellie U Lee
NPI 1104034107
$5,774.44
in general payments reported to CMS, 2019-2025
12 companies · $582 in 2025
The $582 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,057 · 2020: $925 · 2021: $1,213 · 2022: $976 · 2023: $795 · 2024: $226 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,603.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,980.66 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Mycarelink |
| Boehringer Ingelheim Pharmaceuticals, INC. | $795.33 | 2019-2022 | |
| Novo Nordisk INC | $629.83 | 2019-2023 | |
| Boston Scientific Corporation | $387.98 | 2020-2022 | |
| Amgen INC. | $387.84 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $385.44 | 2019-2023 | Lifevest |
| Amarin Pharma, INC. | $366.80 | 2019-2021 | |
| Medtronic Vascular, INC. | $333.10 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $249.96 | 2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $117.19 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $114.65 | 2023 | Camzyos |
| Janssen Pharmaceuticals, INC | $25.66 | 2019-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nellie Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.